Study analysis · Lancet · 2019
Could eating more fiber be the secret to living longer? A massive new study says yes—25-29 grams daily cuts heart disease and cancer risk by up to 30%.
Eating about 25-29 grams of fiber a day from foods like fruits, vegetables, and whole grains is linked to a 15-30% lower risk of dying from heart disease, stroke, diabetes, and colon cancer.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
In simple terms
This study is like a recipe for a specific surgical method. It shows you step-by-step how the surgeons do it, but it doesn't prove that this method works better than other methods. So we can only say 'this is how they do it' and not 'this is the best way'.
What’s the bottom line?
Scientists looked at many studies and found that people who eat 25-29 grams of fibre per day (from fruits, vegetables, whole grains) are less likely to die from heart disease, stroke, diabetes, and colon cancer. Eating even more fibre might be even better. Whole grains also help, but the evidence is not as strong.
How strong is this study?
This study is like a one-sided story—it only describes what the surgeons did, without comparing to other ways or checking results carefully. That means we can't be very sure if the method is truly safe or effective, because we don't have a fair comparison.
40 / 100
- COI disclosure+40/40
- Data availabilitydata not shared
- Code availabilitycode not shared
0 / 100
- Randomizationnot randomized
- Blindingnot blinded
- Control groupno control group
- Sample sizeno sample size reported
- Follow-upno follow-up reported
100 / 100
0 / 100
- P-valuesno p-values reported
- Effect sizeno effect size reported
- Confidence intervalsno confidence intervals
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 528 / 100
Probability of being correct
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
This design cannot establish causation — the findings describe an association, not a cause. Case series are descriptive and lack a control group, so causation cannot be inferred. No comparison or randomization exists.
Moderate COI
Moderate conflicts that may influence study outcomes
Several authors have financial relationships with Intuitive Surgical, the manufacturer of the da Vinci robotic system, and other medical device companies, which may influence the study's favorable description of a robotic technique.
Conflict Details
Intuitive Surgical: speaking, lecture fees, and training courses
Fruit Street, Informed Inc, NovaNav, Tego, Commend Corporation, Intuitive Surgical, Johnson & Johnson, Rolo-7, C4, Coop-Lor-Corporation, Frontiers in Surgery: equity, intellectual property, consulting, advisory roles, CEO, editor
Medtronic, Steris, Boston Scientific: honoraria
The study describes a robotic surgical technique. The authors have significant financial ties to Intuitive Surgical, the manufacturer of the robotic platform used. Dr Cerfolio has multiple roles and equity in several companies. No independent analysis safeguards are mentioned. The absence of a funding statement may indicate no external funding, but the conflicts of interest are notable.
Key takeaways
- 01
People who eat the most fibre have 15-30% lower risk of dying from heart disease, stroke, diabetes, and colon cancer.
- 02
In experiments, eating more fibre also lowered body weight, blood pressure, and cholesterol.
- 03
Yes, the reductions are large enough to matter for public health.
- 04
For example, a 15-30% risk reduction could prevent many thousands of deaths each year if everyone ate enough fibre.
Surprising findings
- Glycemic index and glycemic load had little to no association with disease risk, despite being widely promoted.Many popular diets emphasize low GI foods, but this large analysis found minimal evidence for their benefit.
- Higher fiber intakes (>29 g/day) may provide even greater benefits, with no upper limit observed.Often there's a sweet spot, but here the dose-response curve suggests more fiber could be even better.
Practical takeaways
Eat at least 25-29 grams of fiber daily from whole foods like oats, beans, lentils, apples, and broccoli.
The results are for the general population without chronic disease; individuals with certain conditions may need different guidance.
medium confidenceWhy this study matters
The Magic Number: 25-29 Grams
Observational data from nearly 135 million person-years show that consuming 25-29 g of dietary fiber daily is associated with a 15-30% decrease in all-cause mortality, cardiovascular mortality, and incidence of coronary heart disease, stroke, type 2 diabetes, and colorectal cancer. Dose-response analyses suggest even greater benefits with higher intakes.
This gives a clear, actionable target for anyone looking to improve their health and longevity.
Fiber vs. Glycemic Index: Which Matters More?
The study found that fiber and whole grains have strong protective effects, but glycemic index/load showed minimal or no association with outcomes, and the evidence for GI/GL was graded low to very low. This challenges popular diet advice that focuses on low GI foods.
Many people focus on low-GI diets, but this suggests fiber intake may be more important.
Confidence: Moderate for Fiber, Low for Whole Grains
The GRADE certainty of evidence was moderate for dietary fiber, low to moderate for whole grains, and low to very low for glycemic index/load. So the strongest recommendation is for fiber.
Not all nutrition advice is created equal; this helps people prioritize what to focus on.
Want the whole report?
Detailed mode opens the full scientific breakdown — every score component, the methodology, conflicts of interest, the evidence analysis behind each claim, and the raw study data.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Scientists looked at many studies and found that people who eat 25-29 grams of fibre per day (from fruits, vegetables, whole grains) are less likely to die from heart disease, stroke, diabetes, and colon cancer. Eating even more fibre might be even better. Whole grains also help, but the evidence is not as strong.
Research results
People who eat the most fibre have 15-30% lower risk of dying from heart disease, stroke, diabetes, and colon cancer. In experiments, eating more fibre also lowered body weight, blood pressure, and cholesterol.
What this means - more context
Yes, the reductions are large enough to matter for public health. For example, a 15-30% risk reduction could prevent many thousands of deaths each year if everyone ate enough fibre.
To quantify the predictive potential of carbohydrate quality markers (dietary fibre, whole grains, glycemic index/load) for non-communicable diseases and to establish evidence-based intake recommendations.
This series of systematic reviews and meta-analyses found that high dietary fibre intake (25-29 g/day) is associated with 15-30% reductions in all-cause mortality, cardiovascular mortality, coronary heart disease, stroke, type 2 diabetes, and colorectal cancer. Higher intakes may offer greater benefits. Whole grain intake showed similar but weaker associations. Glycemic index/load had minimal or no association with outcomes.
Methods Used
Systematic reviews and meta-analyses of 185 prospective studies (≈135 million person-years) and 58 randomized controlled trials (4635 participants). Literature searches in PubMed, Ovid MEDLINE, Embase, Cochrane. Duplicate data extraction and bias assessment. GRADE used for evidence quality.
Main Finding
Consuming 25-29 g of dietary fibre per day is associated with a 15-30% reduction in all-cause and cardiovascular mortality, coronary heart disease, stroke, type 2 diabetes, and colorectal cancer. Randomised trials confirm lower body weight, systolic blood pressure, and total cholesterol with higher fibre intake.
Confidence Level
Moderate certainty for dietary fibre; low to moderate for whole grains; low to very low for glycemic index/load.
Study Flags
Red Flags
- •Observational data may be confounded despite adjustments
- •GRADE evidence quality low to very low for glycemic index/load
- •Limited to general population; excludes those with chronic disease
No biological mechanisms were identified in this study. This may be an epidemiological, observational, or survey-based study that reports associations rather than proposing causal biological pathways.
Surprising Findings
Glycemic index and glycemic load had little to no association with disease risk, despite being widely promoted.
Many popular diets emphasize low GI foods, but this large analysis found minimal evidence for their benefit.
Practical Takeaways
Eat at least 25-29 grams of fiber daily from whole foods like oats, beans, lentils, apples, and broccoli.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 528 / 100
Probability of being correct
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
Human Case Report
Subject
Lower probability
on the GRADE evidence scale
This study is like a recipe for a specific surgical method. It shows you step-by-step how the surgeons do it, but it doesn't prove that this method works better than other methods. So we can only say 'this is how they do it' and not 'this is the best way'.
Moderate conflicts detected — such as industry funding with partial involvement. A meaningful penalty has been applied.
Strengths
- Detailed step-by-step description with video supplements
- Clear indication criteria for the technique
- Based on established surgical principles
Weaknesses
- No control group or comparison arm
- No quantitative outcome data (e.g., complication rates, success rates)
- Potential selection bias (only successful cases likely presented)
Methodology
Evidence Keywords
Statistical Reporting
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Scientists looked at many studies and found that people who eat 25-29 grams of fibre per day (from fruits, vegetables, whole grains) are less likely to die from heart disease, stroke, diabetes, and colon cancer. Eating even more fibre might be even better. Whole grains also help, but the evidence is not as strong.
Research results
People who eat the most fibre have 15-30% lower risk of dying from heart disease, stroke, diabetes, and colon cancer. In experiments, eating more fibre also lowered body weight, blood pressure, and cholesterol.
What this means - more context
Yes, the reductions are large enough to matter for public health. For example, a 15-30% risk reduction could prevent many thousands of deaths each year if everyone ate enough fibre.
To quantify the predictive potential of carbohydrate quality markers (dietary fibre, whole grains, glycemic index/load) for non-communicable diseases and to establish evidence-based intake recommendations.
This series of systematic reviews and meta-analyses found that high dietary fibre intake (25-29 g/day) is associated with 15-30% reductions in all-cause mortality, cardiovascular mortality, coronary heart disease, stroke, type 2 diabetes, and colorectal cancer. Higher intakes may offer greater benefits. Whole grain intake showed similar but weaker associations. Glycemic index/load had minimal or no association with outcomes.
Methods Used
Systematic reviews and meta-analyses of 185 prospective studies (≈135 million person-years) and 58 randomized controlled trials (4635 participants). Literature searches in PubMed, Ovid MEDLINE, Embase, Cochrane. Duplicate data extraction and bias assessment. GRADE used for evidence quality.
Main Finding
Consuming 25-29 g of dietary fibre per day is associated with a 15-30% reduction in all-cause and cardiovascular mortality, coronary heart disease, stroke, type 2 diabetes, and colorectal cancer. Randomised trials confirm lower body weight, systolic blood pressure, and total cholesterol with higher fibre intake.
Confidence Level
Moderate certainty for dietary fibre; low to moderate for whole grains; low to very low for glycemic index/load.
Study Flags
Red Flags
- •Observational data may be confounded despite adjustments
- •GRADE evidence quality low to very low for glycemic index/load
- •Limited to general population; excludes those with chronic disease
No biological mechanisms were identified in this study. This may be an epidemiological, observational, or survey-based study that reports associations rather than proposing causal biological pathways.
Surprising Findings
Glycemic index and glycemic load had little to no association with disease risk, despite being widely promoted.
Many popular diets emphasize low GI foods, but this large analysis found minimal evidence for their benefit.
Practical Takeaways
Eat at least 25-29 grams of fiber daily from whole foods like oats, beans, lentils, apples, and broccoli.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 528 / 100
Probability of being correct
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
Human Case Report
Subject
Lower probability
on the GRADE evidence scale
This study is like a recipe for a specific surgical method. It shows you step-by-step how the surgeons do it, but it doesn't prove that this method works better than other methods. So we can only say 'this is how they do it' and not 'this is the best way'.
Moderate conflicts detected — such as industry funding with partial involvement. A meaningful penalty has been applied.
Strengths
- Detailed step-by-step description with video supplements
- Clear indication criteria for the technique
- Based on established surgical principles
Weaknesses
- No control group or comparison arm
- No quantitative outcome data (e.g., complication rates, success rates)
- Potential selection bias (only successful cases likely presented)
Methodology
Evidence Keywords
Statistical Reporting
Scoring
How strong is this study?
This study is like a one-sided story—it only describes what the surgeons did, without comparing to other ways or checking results carefully. That means we can't be very sure if the method is truly safe or effective, because we don't have a fair comparison.
40 / 100
- COI disclosure+40/40
- Data availabilitydata not shared
- Code availabilitycode not shared
0 / 100
- Randomizationnot randomized
- Blindingnot blinded
- Control groupno control group
- Sample sizeno sample size reported
- Follow-upno follow-up reported
100 / 100
0 / 100
- P-valuesno p-values reported
- Effect sizeno effect size reported
- Confidence intervalsno confidence intervals
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 528 / 100
Probability of being correct
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
This design cannot establish causation — the findings describe an association, not a cause. Case series are descriptive and lack a control group, so causation cannot be inferred. No comparison or randomization exists.
Moderate COI
Moderate conflicts that may influence study outcomes
Several authors have financial relationships with Intuitive Surgical, the manufacturer of the da Vinci robotic system, and other medical device companies, which may influence the study's favorable description of a robotic technique.
Conflict Details
Intuitive Surgical: speaking, lecture fees, and training courses
Fruit Street, Informed Inc, NovaNav, Tego, Commend Corporation, Intuitive Surgical, Johnson & Johnson, Rolo-7, C4, Coop-Lor-Corporation, Frontiers in Surgery: equity, intellectual property, consulting, advisory roles, CEO, editor
Medtronic, Steris, Boston Scientific: honoraria
The study describes a robotic surgical technique. The authors have significant financial ties to Intuitive Surgical, the manufacturer of the robotic platform used. Dr Cerfolio has multiple roles and equity in several companies. No independent analysis safeguards are mentioned. The absence of a funding statement may indicate no external funding, but the conflicts of interest are notable.